Catalent Pharma Solutions

Catalent, based in Philadelphia, PA, is a leading provider of integrated development solutions for pharmaceutical, biotech, and consumer health companies. With a focus on oral dose development, bioavailability enhancement, and formulation services, Catalent offers a wide range of solutions to help innovators deliver superior products that improve people's lives. As the #1 partner in contract development and manufacturing organization (CDMO) services, Catalent is committed to long-term progress and corporate responsibility. With a diverse portfolio of drug delivery technologies and manufacturing platforms, Catalent aims to simplify and de-risk programs for emerging biotech companies seeking clinical supply, consumer health, and cell and gene therapy solutions. Generated from the website

Founded in 1971, Antares Pharma, formerly known as Medi-Ject Corporation, is a specialty pharmaceutical product development and pipeline organization. The company develops, produces and markets various drug delivery platforms, including transdermal and advanced transdermal delivery gels that deliver medication with less potential for skin irritation, fast-melt oral disintegrating tablets for patients having difficulty swallowing oral medications, disposable minineedle injection systems that provide subcutaneous injection capabilities with reduced discomfort, as well as reusable needle-free injection systems that deliver precise medication doses through pressurized liquid penetration of the skin without a needle. The company has a number of active partnering programs with several pharmaceutical and distribution companies for the development of indications and applications, including diabetes, growth disorders, obesity, female sexual dysfunction and other hormone therapies. Antares Pharma maintains operations in Trenton, N.J.